Compare BlackRock TCP Capital Corp (TCPC) vs Tempus AI (TEM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BlackRock TCP Capital Corp vs Tempus AI — how do they compare? BlackRock TCP Capital Corp trades at $4.04 (market cap $332.25M), while Tempus AI trades at $70 (market cap $12.77B). The key difference: Tempus AI is far larger — about 38.4× BlackRock TCP Capital Corp's market cap, and BlackRock TCP Capital Corp pays a 19.19% dividend while Tempus AI pays none. Which is the better fit depends on your goals — on Pluang, investors hold BlackRock TCP Capital Corp for 88 Days and Tempus AI for 22 Days on average.
| TCPC | TEM | |
|---|---|---|
Market Cap | $332.25M | $12.77B |
Volume | 567,148 | 8,980,490 |
Sector | Financials | Broad Market / Factor |
52-Week High | $6.20 | $99.28 |
52-Week Low | $3.13 | $41.55 |
Typical Hold Time | 88 Days | 22 Days |
Enterprise Value | $1.08B | $13.40B |
Dividend Yield | 19.19% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
TCPC trades at $3.94, down 1.25% with a bearish technical outlook. The company reported negative revenue and net income trends from 2024-2026, though recent Q2 2026 earnings beat expectations. A strategic portfolio sale of $523 million aims to reduce leverage and improve liquidity. Analyst sentiment is mixed with 30.77% buy ratings but predominantly hold recommendations.
TCPC faces significant fundamental challenges with declining revenue and negative profitability metrics. The ongoing strategic review and portfolio cleanup may offer long-term value, but investors should weigh the high dividend yield against persistent negative cash flow and earnings trends. Key risks include execution of the strategic review and broader private credit market conditions.
Tempus AI (TEM) trades at $70.29, down 2.35% on the day, with a bullish technical signal despite negative profitability. Recent FDA clearance for its ECG-MR AI product and 13 abstracts accepted for ESMO Congress 2026 highlight ongoing innovation. Revenue grew to $1.4B in 2026, though net losses persist. The stock shows strong analyst support with a $72.60 consensus target and 64% buy ratings.
Outlook remains cautiously optimistic driven by AI healthcare adoption and data licensing growth, but high valuation multiples and sustained losses pose risks. Investor sentiment is positive amid recent insider selling and institutional interest, yet profitability challenges and competitive pressures require monitoring for long-term value creation.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About BlackRock TCP Capital Corp
BlackRock TCP Capital Corp is a finance company specializing in middle-market lending. It aims for high returns through income and capital appreciation while prioritizing principal protection. The company invests in debt securities and earns revenue from interest payments, fees, and some equity appreciation.
Read more on TCPC →About Tempus AI
Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.
Read more on TEM →
